Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
AstraZeneca
Citi
Johnson and Johnson
Boehringer Ingelheim
Chubb
Mallinckrodt
Daiichi Sankyo
Medtronic

Generated: October 21, 2017

DrugPatentWatch Database Preview

Adefovir dipivoxil - Generic Drug Details

« Back to Dashboard

What are the generic sources for adefovir dipivoxil and what is the scope of adefovir dipivoxil patent protection?

Adefovir dipivoxil
is the generic ingredient in two branded drugs marketed by Gilead and Sigmapharm Labs Llc, and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Adefovir dipivoxil has sixty-four patent family members in twenty-five countries and three supplementary protection certificates in three countries.

There are eight drug master file entries for adefovir dipivoxil. Three suppliers are listed for this compound.

Summary for Generic Name: adefovir dipivoxil

US Patents:1
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list8
Suppliers / Packagers: see list3
Bulk Api Vendors: see list77
Clinical Trials: see list134
Patent Applications: see list5,937
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:adefovir dipivoxil at DailyMed

Pharmacology for Ingredient: adefovir dipivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sigmapharm Labs Llc
ADEFOVIR DIPIVOXIL
adefovir dipivoxil
TABLET;ORAL202051-001Aug 29, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Gilead
HEPSERA
adefovir dipivoxil
TABLET;ORAL021449-001Sep 20, 2002ABRXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: adefovir dipivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gilead
HEPSERA
adefovir dipivoxil
TABLET;ORAL021449-001Sep 20, 2002► Subscribe► Subscribe
Gilead
HEPSERA
adefovir dipivoxil
TABLET;ORAL021449-001Sep 20, 2002► Subscribe► Subscribe
Gilead
HEPSERA
adefovir dipivoxil
TABLET;ORAL021449-001Sep 20, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: adefovir dipivoxil

Country Document Number Estimated Expiration
Austria277936► Subscribe
Hong Kong1051693► Subscribe
Austria228357► Subscribe
Turkey200200117► Subscribe
South Korea100700089► Subscribe
Colombia4980869► Subscribe
China1347695► Subscribe
European Patent Office1256585► Subscribe
Slovenia1256585► Subscribe
European Patent Office1256584► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: ADEFOVIR DIPIVOXIL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0034France► SubscribePRODUCT NAME: ADEFOVIR DIPIVOXIL; REGISTRATION NO/DATE: EU/1/03/251/001 20030306
00131Netherlands► SubscribePRODUCT NAME: ADEFOVIR DIPIVOXIL, DESGEWENST IN DE VORM VAN FARMACEUTISCH AANVAARDBARE ZUURADDITIE ZOUTEN, METAALZOUTEN EN SOLVATEN HIERVAN; NAT. REGISTRATION NO/DATE: EU/1/03/251/001 20030306; FIRST REGISTRATION: EU/1/03/251/001 20030306
C/GB03/030United Kingdom► SubscribePRODUCT NAME: ADEFOVIR DIPIVOXIL; REGISTERED: UK EU/1/03/251/001 20030306
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Teva
McKinsey
UBS
Dow
Queensland Health
Express Scripts
Fuji
Federal Trade Commission
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot